1. Analysis of bolt-to-laminate interface friction in bolted composite joint with interference-fit. (June 2015) Authors: Yuanxin, D.; Yuan, L.; Kaifu, Z.; Ping, L.; Jian, L. Journal: Materials research innovations Issue: Volume 19(2015)Supplement 6 Page Start: S6-42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Analysis of bolt-to-laminate interface friction in bolted composite joint with interference-fit. (June 2015) Authors: Yuanxin, D.; Yuan, L.; Kaifu, Z.; Ping, L.; Jian, L. Journal: Materials research innovations Issue: Volume 19:Number 6(2015) Page Start: S6-42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CAMRELIZUMAB COMBINED WITH GEMOX IN PATIENTS WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA. (17th June 2021) Authors: Xie, Y.; Mi, L.; Zheng, W.; Ping, L.; Lin, N.; Tu, M.; Zhang, C.; Ying, Z.; Liu, W.; Deng, L.; W, M.; Du, T.; Tang, Y.; Wang, X.; Zhu, J.; Song, Y. Journal: Hematological oncology Issue: Volume 39(2021)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CLINICAL FEATURES AND PROGNOSES OF PRIMARY GASTRIC DIFFUSE LARGE B CELL LYMPHOMA: A RETROSPECTIVE ANALYSIS OF 139 CHINESE CASES WITH IMMUNOPHENOTYPING FROM CLAP. (June 2017) Authors: Song, Y.; Cen, X.; Wu, M.; Shen, Y.; Leng, X.; Ping, L.; Xie, Y.; Zhu, J. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 378 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Elimination of coagulation factor XIII from fibrinogen preparations. Issue 5 (15th May 2013) Authors: Smith, E. L.; Cardinali, B.; Ping, L.; Ariëns, R. A. S.; Philippou, H. Journal: Journal of thrombosis and haemostasis Issue: Volume 11:Issue 5(2013) Page Start: 993 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FIRST‐LINE L‐ASPARAGINASE‐BASED CHEMOTHERAPY PLUS RADIOTHERAPY IS ACTIVE IN STAGE I/II EXTRANODAL NK/T‐CELL LYMPHOMA: RESULTS FROM PEKING UNIVERSITY CANCER HOSPITAL. (June 2017) Authors: Song, Y.; Jia, J.; Wu, M.; Leng, X.; Lin, N.; Xie, Y.; Zheng, W.; Wang, X.; Ping, L.; Tu, M.; Ying, Z.; Zhang, C.; Liu, W.; Deng, L.; Zhu, J. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Improved outcome for patients with relapsed/refractory mantle cell lymphoma (MCL) who stop ibrutinib +/− rituximab for reasons other than progression of disease. (June 2017) Authors: Chen, W.; Zeng, D.; Desai, A.; Badillo, M.; Feng, L.; Yan, F.; Nomie, K.; Ping, L.; Ye, H.; Liang, Y.; Lee, H.; Oki, Y.; Romaguera, J.; Wang, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P1090: CAMRELIZUMAB (CAM) COMBINED WITH GEMOX CHEMOTHERAPY RESULTS IN HIGH COMPLETE METABOLIC RESPONSE RATES IN RELAPSED/REFRACTORY CLASSIC HODGKIN LYMPHOMA (CHL): A PHASE II TRIAL. (23rd June 2022) Authors: Xie, Y.; Tang, Y.; Zheng, W.; Ping, L.; Lin, N.; Tu, M.; Zhang, C.; Ying, Z.; Liu, W.; Deng, L.; Wu, M.; Mi, L.; Du, T.; Wang, X.; Zhu, J.; Song, Y. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 980 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. THE BRUTON'S TYROSINE KINASE INHIBITOR IBRUTINIB EXERTS IMMUNOMODULATORY ACTIVITY TOWARDS TUMOR‐INFILTRATING MACROPHAGES. (June 2017) Authors: Ding, N.; Ping, L.; Shi, Y.; Feng, L.; Li, J.; Liu, Y.; Lin, Y.; Shi, C.; Wang, X.; Pan, Z.; Song, Y.; Zhu, J. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 402 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. TREATMENT STRATEGIES AND PROGNOSTIC FACTORS OF PRIMARY GASTRIC DIFFUSE LARGE B CELL LYMPHOMA: A RETROSPECTIVE STUDY OF 303 CASES FROM CHINA LYMPHOMA PATIENT REGISTRY. (June 2017) Authors: Song, Y.; Cen, X.; Yang, H.; Wu, M.; Shen, Y.; Lei, T.; Leng, X.; Ping, L.; Xie, Y.; Zhu, J. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 378 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗